• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Efficacy and effectiveness of live attenuated influenza vaccine in school-age children

tetano

Editor, Senior Moderator
Expert Rev Vaccines. 2015 Oct;14(10):1331-46. doi: 10.1586/14760584.2015.1078732. Epub 2015 Sep 7.
[h=1]Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.[/h] Coelingh K[SUP]1[/SUP], Olajide IR[SUP]2[/SUP], MacDonald P[SUP]1[/SUP], Yogev R[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Evidence of high efficacy of live attenuated influenza vaccine (LAIV) from randomized controlled trials is strong for children 2-6 years of age, but fewer data exist for older school-age children. We reviewed the published data on efficacy and effectiveness of LAIV in children ≥5 years. QUOSA (Elsevier database) was searched for articles published from January 1990 to June 2014 that included 'FluMist', 'LAIV', 'CAIV', 'cold adapted influenza vaccine', 'live attenuated influenza vaccine', 'live attenuated cold adapted' or 'flu mist'. Studies evaluated included randomized controlled trials, effectiveness and indirect protection studies. This review demonstrates that LAIV has considerable efficacy and effectiveness in school-age children.


[h=4]KEYWORDS:[/h] effectiveness; efficacy; influenza vaccine; live attenuated influenza vaccine; school-age children

PMID: 26372891 [PubMed - in process]
 
Back
Top Bottom